Benzinga | Nov 4, 2020 07:09AM EST

Ionis Pharmaceuticals Q3 EPS $(0.22) Misses $(0.09) Estimate, Sales $160.00M Miss $182.14M Estimate

Ionis Pharmaceuticals (NASDAQ:IONS) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.09) by 144.44 percent. This is a 222.22 percent decrease over earnings of $0.18 per share from the same period last year. The company reported quarterly sales of $160.00 million which missed the analyst consensus estimate of $182.14 million by 12.16 percent. This is a 4.76 percent decrease over sales of $168.00 million the same period last year.